These cell types, along with dysfunctional CD8+ T cells, DCs [16], regulatory B cells (Breg cells), and neutrophils, among others [17], attenuate anti-HCC immune surveillance and effector functions. The gene discussed is CD8A; the disease is hepatocellular carcinoma.